|
1
|
Perveen S: Frequency and impact of
hypertensive disorders of pregnancy. J Ayub Med Coll Abbottabad.
26:518–521. 2014.PubMed/NCBI
|
|
2
|
Duley L: Maternal mortality associated
with hypertensive disorders of pregnancy in Africa, Asia, Latin
America and the Caribbean. Br J Obstet Gynaecol. 99:547–553. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith GC, Stenhouse EJ, Crossley JA,
Aitken DA, Cameron AD and Connor JM: Early pregnancy levels of
pregnancy-associated plasma protein A and the risk of intrauterine
growth restriction, premature birth, preeclampsia, and stillbirth.
J Clin Endocrinol Metab. 87:1762–1767. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bersinger NA, Smárason AK, Muttukrishna S,
Groome NP and Redman CW: Women with preeclampsia have increased
serum levels of pregnancy-associated plasma protein A (PAPP-A),
inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy.
22:45–55. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Svedas E, Islam KB, Nisell H and
Kublickiene KR: Vascular endothelial growth factor induced
functional and morphologic signs of endothelial dysfunction in
isolated arteries from normal pregnant women. Am J Obstet Gynecol.
188:168–176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luizon MR, Sandrim VC, Palei AC, Lacchini
R, Cavalli RC, Duarte G and Tanus-Santos JE: Epistasis among eNOS,
MMP-9 and VEGF maternal genotypes in hypertensive disorders of
pregnancy. Hypertens Res. 35:917–921. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Razak A, Florendo-Chin A, Banfield L,
Abdul Wahab MG, McDonald S, Shah PS and Mukerji A:
Pregnancy-induced hypertension and neonatal outcomes: a systematic
review and meta-analysis. J Perinatol. 38:46–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishimitsu T: Starting the new review
series: Pregnancy-induced hypertension. Hypertension Research.
40:3–4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silahtaroglu AN, Tümer Z, Kristensen T,
Sottrup-Jensen L and Tommerup N: Assignment of the human gene for
pregnancy-associated plasma protein A (PAPPA) to 9q33.1 by
fluorescence in situ hybridization to mitotic and meiotic
chromosomes. Cytogenet Cell Genet. 62:214–216. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin TM, Galbert SP, Kiefer D, Spellacy WN
and Gall S: Characterization of four human pregnancy-associated
plasma proteins. Am J Obstet Gynecol. 118:223–236. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Folkersen J, Grudzinskas JG, Hindersson P,
Teisner B and Westergaard JG: Pregnancy-associated plasma protein
A: circulating levels during normal pregnancy. Am J Obstet Gynecol.
139:910–914. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jussila L and Alitalo K: Vascular growth
factors and lymphangiogenesis. Physiol Rev. 82:673–700. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rak J, Yu JL, Klement G and Kerbel RS:
Oncogenes and angiogenesis: Signaling three-dimensional tumor
growth. J Investig Dermatol Symp Proc. 5:24–33. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duyndam MC, Hilhorst MC, Schlüper HM,
Verheul HM, van Diest PJ, Kraal G, Pinedo HM and Boven E: Vascular
endothelial growth factor-165 overexpression stimulates
angiogenesis and induces cyst formation and macrophage infiltration
in human ovarian cancer xenografts. Am J Pathol. 160:537–548. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nanaev A, Frank HG, Chwalisz K and
Kaufmann P: Physiological dilatation of uteroplacental arteries in
the guinea pig is related to nos-activity of invasive trophoblast.
Placenta. 16:A511995.
|
|
17
|
Rutherford RA, McCarthy A, Sullivan MH,
Elder MG, Polak JM and Wharton J: Nitric oxide synthase in human
placenta and umbilical cord from normal, intrauterine
growth-retarded and pre-eclamptic pregnancies. Br J Pharmacol.
116:3099–3109. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lam PM, Po LS, Cheung LP and Haines C: The
effect of exogenous estradiol treatment on the mRNA expression of
vascular endothelial growth factor and its receptors in cultured
human oviduct mucosal cells. J Assist Reprod Genet. 22:251–255.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsatsaris V, Goffin F, Munaut C, Brichant
JF, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F and
Foidart JM: Overexpression of the soluble vascular endothelial
growth factor receptor in preeclamptic patients: pathophysiological
consequences. J Clin Endocrinol Metab. 88:5555–5563. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dekker GA: Risk factors for preeclampsia.
Clin Obstet Gynecol. 42:422–435. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abi-Said D, Annegers JF, Combs-Cantrell D,
Frankowski RF and Willmore LJ: Case-control study of the risk
factors for eclampsia. Am J Epidemiol. 142:437–441. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schuiling GA and Faas MM: Etiology and
pathogenesis of preeclampsia: current concepts. Am J Obstet
Gynecol. 181:1036–1037. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robillard PY, Dekker GA and Hulsey TC:
Revisiting the epidemiological standard of preeclampsia:
Primigravidity or primipaternity? Eur J Obstet Gynecol Reprod Biol.
84:37–41. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoff C, Peevy K, Giattina K, Spinnato JA
and Peterson RD: Maternal-fetal HLA-DR relationships and
pregnancy-induced hypertension. Obstet Gynecol. 80:1007–1012.
1992.PubMed/NCBI
|
|
25
|
Sletnes KE, Wisløff F, Moe N and Dale PO:
Antiphospholipid antibodies in pre-eclamptic women: relation to
growth retardation and neonatal outcome. Acta Obstet Gynecol Scand.
71:112–117. 1992. View Article : Google Scholar : PubMed/NCBI
|
